AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2.
Wang
Wei
W
Department of Experimental Anaesthesiology, University Hospital Freiburg, Center for Clinical Research, Breisacher Strasse 66, Freiburg, Germany.
Schwemmers
Sven
S
Hexner
Elizabeth O
EO
Pahl
Heike L
HL